Back
Corporate News
Vivo Bio Tech shareholders approved financials and re-appointed directors at AGM on September 30, 2026
30-Sep-2026, 07:45
Vivo Bio Tech Limited informed the BSE on Wednesday, September 30, 2026, that its 39th Annual General Meeting (AGM) was held via video conference, where shareholders approved the audited standalone and consolidated financial statements for the year ended March 31, 2026, and re-appointed Mr. Kalyan Ram Mangipudi, Mr. Sri Kalyan Kompella, and Dr. Sankaranarayanan Alangudi as directors, with terms extending for five consecutive years, subject to shareholder approval. The company also noted that remote e-voting commenced on September 27, 2026, and voting results will be disseminated and uploaded on the company's website and CDSL platform by October 3, 2026.